These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 9621421

  • 1. Synthesis of dipeptide-type human immunodeficiency virus (HIV) protease inhibitors with a binding unit to gp120.
    Asagarasu A, Takayanagi N, Achiwa K.
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):867-70. PubMed ID: 9621421
    [Abstract] [Full Text] [Related]

  • 2. Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120.
    Asagarasu A, Uchiyama T, Achiwa K.
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):697-703. PubMed ID: 9579045
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and human immunodeficiency virus (HIV)-1 protease inhibitory activity of tripeptide analogues containing a dioxoethylene moiety.
    Kitazaki T, Asano T, Kato K, Kishimoto S, Itoh K.
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2636-40. PubMed ID: 7697778
    [Abstract] [Full Text] [Related]

  • 4. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y, Matsumoto H, Mizumoto S, Kimura T, Fujiwara Y, Akaji K.
    Biopolymers; 1999 Dec; 51(1):59-68. PubMed ID: 10380353
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective synthesis of beta-substituted phenylalanine-beta-phenylisoserine-derived tripeptides using N-cinnamoyl-L-proline as template: synthesis of structural analogues of HIV protease inhibitors.
    Saha B, Nandy JP, Shukla S, Siddiqui I, Iqbal J.
    J Org Chem; 2002 Nov 01; 67(22):7858-60. PubMed ID: 12398514
    [Abstract] [Full Text] [Related]

  • 6. Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
    Sakurai M, Higashida S, Sugano M, Handa H, Komai T, Yagi R, Nishigaki T, Yabe Y.
    Chem Pharm Bull (Tokyo); 1994 Mar 01; 42(3):534-40. PubMed ID: 8004698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors.
    Martin SF, Dorsey GO, Gane T, Hillier MC, Kessler H, Baur M, Mathä B, Erickson JW, Bhat TN, Munshi S, Gulnik SV, Topol IA.
    J Med Chem; 1998 May 07; 41(10):1581-97. PubMed ID: 9572884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R, Ohagen A, Nicol F, Del Vecchio AM, Jonckers TH, Goethals O, Van Loock M, Michiels L, Grigsby J, Xu Z, Zhang YP, Gutshall LL, Cunningham M, Jiang H, Bola S, Sarisky RT, Hertogs K.
    Antiviral Res; 2009 Nov 07; 84(2):142-9. PubMed ID: 19699239
    [Abstract] [Full Text] [Related]

  • 16. Endothiopeptide inhibitors of HIV-1 protease.
    Yao S, Zutshi R, Chmielewski J.
    Bioorg Med Chem Lett; 1998 Mar 17; 8(6):699-704. PubMed ID: 9871586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.